Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol

作者: Anette Küster , Alfredo C. Alder , Beate Escher , Karen Duis , Kathrin Fenner

DOI: 10.1897/IEAM_2009-050.1

关键词:

摘要: … However, atenolol should not be considered as representative for other β‐blockers, such as metoprolol, oxprenolol, and propranolol, some of which show significantly different …

参考文章(5)
K. Balon, B. U. Riebesehl, B. W. Müller, Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption Pharmaceutical Research. ,vol. 16, pp. 882- 888 ,(1999) , 10.1023/A:1018882221008
Salwa K Poole, Colin F Poole, Chromatographic models for the sorption of neutral organic compounds by soil from water and air Journal of Chromatography A. ,vol. 845, pp. 381- 400 ,(1999) , 10.1016/S0021-9673(98)01085-1
H.-J Klimisch, M Andreae, U Tillmann, A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data Regulatory Toxicology and Pharmacology. ,vol. 25, pp. 1- 5 ,(1997) , 10.1006/RTPH.1996.1076
David Pascoe, Wanchamai Karntanut, Carsten T Müller, Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris Chemosphere. ,vol. 51, pp. 521- 528 ,(2003) , 10.1016/S0045-6535(02)00860-3
O JONES, N VOULVOULIS, J LESTER, Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research. ,vol. 36, pp. 5013- 5022 ,(2002) , 10.1016/S0043-1354(02)00227-0